Finland
#00276
Implements
#00373 Establish antimicrobial stewardship teams with prescribing audit and feedback
Implementer
Finnish public-health authorities and clinical professional bodies
Location
Description
After macrolide resistance in group A streptococci rose in Finland, national recommendations were issued by public-health authorities and clinical professional bodies to reduce macrolide use for respiratory and skin infections. Macrolide consumption fell sharply within one year and remained below its 1991 level. Resistance in Streptococcus pyogenes declined after the reduction in use, though with a time lag, demonstrating that national prescribing guidance backed by surveillance can reverse population-level resistance for specific pathogen-drug relationships.
Metrics
2Lessons learned
- National prescribing guidance can reduce consumption rapidly when coordinated with surveillance data and professional clinical bodies.
- Resistance decline may lag behind reduced consumption by several years and varies by organism and resistance mechanism — replicators should plan long-term surveillance rather than expecting immediate resistance reversal.